Identity
- Trade Name
- Echo SCreen III Accessories EUDAMED
- Device Name
- ECHO-SCREEN III DOCKING STATION EUDAMED
- Model / Reference
- 011010 EUDAMED010041 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 05713315012020 EUDAMED
- Basic UDI-DI
- 5713315NA001415B EUDAMED
- EMDN Code
- Z129013 GENERAL AUDITORY AND/OR VISUAL STIMULATORS EUDAMED
Classification
- Device Class
- Class I EUDAMED
- Market of Registration
- Denmark EUDAMED
Clinical & Handling
Sterile
Yes
EUDAMED
Implantable
No
EUDAMED
Reusable
Yes
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Category: Auditory stimulator
Echo SCreen III Accessories by Natus Medical Denmark ApS — Class I — MDR — listed in EUDAMED — regulatory data on deviCERTS
Similar devices
Also classified as Auditory stimulator.
- Protektor32 Pods and Pod Kit — NATUS MEDICAL INCORPORATED DBA EXCEL-TECH LTD (XLTEK) · Class I
- GN Otometrics A/S — Natus Medical Denmark ApS · Class II
- GN Otometrics A/S — Natus Medical Denmark ApS · Class II
- Nucleus — Cochlear · Class III
- GN Otometrics A/S — Natus Medical Denmark ApS · Class II
- GN Otometrics A/S — Natus Medical Denmark ApS · Class II
- Protektor32 Pods and Pod Kit — NATUS MEDICAL INCORPORATED DBA EXCEL-TECH LTD (XLTEK) · Class I
- ER-1 — ETYMOTIC RESEARCH, INC. · Class II
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 5713315NA001415B | Class I | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Natus Medical Denmark ApS
- EUDAMED SRN
- DK-MF-000001617
Sources (1)
- EUDAMED c1002276-0c02-4e84-a921-4bb762600ac0 61 fields · synced Jun 18, 2026